We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RADI
2651
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$217K ﹤0.01%
18,330
-548,135
-97% -$5.68M
ITRN icon
2652
Ituran Location and Control
ITRN
$1.04B
$216K ﹤0.01%
+10,199
New +$233K
THCHW
2653
CALL
DELISTED
TH International Limited Warrant
THCHW
$214K ﹤0.01%
77,124
-722,733
-90% -$127K
NFGC
2654
New Found Gold
NFGC
$638M
$214K ﹤0.01%
+52,997
New +$203K
BHIL.WS
2655
CALL
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$213K ﹤0.01%
83,383
-5,311
-6% -$1.71K
CYXT
2656
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$212K ﹤0.01%
110,334
-310,812
-74% -$734K
EDIT icon
2657
Editas Medicine
EDIT
$453M
$212K ﹤0.01%
+23,867
New +$262K
HCKT icon
2658
Hackett Group
HCKT
$285M
$212K ﹤0.01%
+10,389
New +$220K
PNR icon
2659
Pentair
PNR
$10.7B
$211K ﹤0.01%
+4,700
New +$204K
TAL icon
2660
TAL Education Group
TAL
$6.75B
$211K ﹤0.01%
29,878
-72,198
-71% -$400K
CNX icon
2661
CNX Resources
CNX
$5.35B
$208K ﹤0.01%
+12,366
New +$213K
CYPH
2662
Cypherpunk Technologies Inc
CYPH
$72.4M
$208K ﹤0.01%
46,243
-15,995
-26% -$107K
DHI icon
2663
D.R. Horton
DHI
$42.2B
$207K ﹤0.01%
2,319
-698,562
-100% -$56M
WNC icon
2664
Wabash National
WNC
$505M
$207K ﹤0.01%
+9,140
New +$198K
ROK icon
2665
Rockwell Automation
ROK
$49.6B
$206K ﹤0.01%
+800
New +$201K
SCHE icon
2666
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$206K ﹤0.01%
+8,700
New +$203K
BEEM icon
2667
Beam Global
BEEM
$25.8M
$205K ﹤0.01%
+11,763
New +$176K
FLGT icon
2668
Fulgent Genetics
FLGT
$523M
$205K ﹤0.01%
6,900
-49,109
-88% -$1.76M
NWPX icon
2669
NWPX Infrastructure Inc
NWPX
$1.08B
$203K ﹤0.01%
+6,030
New +$205K
VOR icon
2670
Vor Biopharma
VOR
$1.28B
$203K ﹤0.01%
+1,524
New +$151K
XTN icon
2671
State Street SPDR S&P Transportation ETF
XTN
$388M
$201K ﹤0.01%
2,994
-2,752
-48% -$192K
MNTN
2672
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$201K ﹤0.01%
19,648
WHWK
2673
Whitehawk Therapeutics
WHWK
$266M
$199K ﹤0.01%
+15,499
New +$202K
ADVM
2674
DELISTED
Adverum Biotechnologies
ADVM
$198K ﹤0.01%
34,140
-16,434
-32% -$125K
IRRX
2675
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
$196K ﹤0.01%
19,000

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.